We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Board Properly Declared Copaxone Patents Invalid, Federal Circuit Finds

Mealey's (October 15, 2018, 1:25 PM EDT) -- WASHINGTON, D.C. — On the same day it affirmed a Delaware federal judge’s determination of invalidity with regard to four patents covering the multiple sclerosis drug Copaxone, the Federal Circuit U.S....
To view the full article, register now.